153 related articles for article (PubMed ID: 7828148)
1. The protooncogene CHOP/GADD153, involved in growth arrest and DNA damage response, is amplified in a subset of human sarcomas.
Forus A; Flørenes VA; Maelandsmo GM; Fodstad O; Myklebost O
Cancer Genet Cytogenet; 1994 Dec; 78(2):165-71. PubMed ID: 7828148
[TBL] [Abstract][Full Text] [Related]
2. Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: some amplica do not include MDM2.
Forus A; Flørenes VA; Maelandsmo GM; Meltzer PS; Fodstad O; Myklebost O
Cell Growth Differ; 1993 Dec; 4(12):1065-70. PubMed ID: 8117620
[TBL] [Abstract][Full Text] [Related]
3. MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status.
Flørenes VA; Maelandsmo GM; Forus A; Andreassen A; Myklebost O; Fodstad O
J Natl Cancer Inst; 1994 Sep; 86(17):1297-302. PubMed ID: 8064888
[TBL] [Abstract][Full Text] [Related]
4. Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas.
Berner JM; Forus A; Elkahloun A; Meltzer PS; Fodstad O; Myklebost O
Genes Chromosomes Cancer; 1996 Dec; 17(4):254-9. PubMed ID: 8946207
[TBL] [Abstract][Full Text] [Related]
5. The 12q13-q15 translocation breakpoints in pleomorphic adenoma and clear-cell sarcoma of tendons and aponeuroses are different from that in myxoid liposarcoma.
Stenman G; Sahlin P; Mark J; Chaganti RS; Kindblom LG; Aman P
Genes Chromosomes Cancer; 1993 Jul; 7(3):178-80. PubMed ID: 7687873
[TBL] [Abstract][Full Text] [Related]
6. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma.
Crozat A; Aman P; Mandahl N; Ron D
Nature; 1993 Jun; 363(6430):640-4. PubMed ID: 8510758
[TBL] [Abstract][Full Text] [Related]
7. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon.
Italiano A; Bianchini L; Keslair F; Bonnafous S; Cardot-Leccia N; Coindre JM; Dumollard JM; Hofman P; Leroux A; Mainguené C; Peyrottes I; Ranchere-Vince D; Terrier P; Tran A; Gual P; Pedeutour F
Int J Cancer; 2008 May; 122(10):2233-41. PubMed ID: 18214854
[TBL] [Abstract][Full Text] [Related]
8. CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of G1/S arrest.
Barone MV; Crozat A; Tabaee A; Philipson L; Ron D
Genes Dev; 1994 Feb; 8(4):453-64. PubMed ID: 8125258
[TBL] [Abstract][Full Text] [Related]
9. Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation.
Kanoe H; Nakayama T; Murakami H; Hosaka T; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Sasaki MS; Toguchida J
Anticancer Res; 1998; 18(4A):2317-21. PubMed ID: 9703873
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity at 12q14-15 often occurs in stage I soft tissue sarcomas and is associated with MDM2 amplification in tumors at various stages.
Taubert H; Schuster K; Brinck U; Bartel F; Kappler M; Lautenschläger C; Bache M; Trump C; Schmidt H; Holzhausen HJ; Würl P; Schlott T
Mod Pathol; 2003 Nov; 16(11):1109-16. PubMed ID: 14614050
[TBL] [Abstract][Full Text] [Related]
11. Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas.
Khatib ZA; Matsushime H; Valentine M; Shapiro DN; Sherr CJ; Look AT
Cancer Res; 1993 Nov; 53(22):5535-41. PubMed ID: 8221695
[TBL] [Abstract][Full Text] [Related]
12. Fusion of the EWS and CHOP genes in myxoid liposarcoma.
Panagopoulos I; Höglund M; Mertens F; Mandahl N; Mitelman F; Aman P
Oncogene; 1996 Feb; 12(3):489-94. PubMed ID: 8637704
[TBL] [Abstract][Full Text] [Related]
13. Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements.
Antonescu CR; Elahi A; Healey JH; Brennan MF; Lui MY; Lewis J; Jhanwar SC; Woodruff JM; Ladanyi M
Clin Cancer Res; 2000 Jul; 6(7):2788-93. PubMed ID: 10914725
[TBL] [Abstract][Full Text] [Related]
14. Mapping of gene loci in the Q13-Q15 region of chromosome 12.
Mitchell EL; White GR; Santibanez-Koref MF; Varley JM; Heighway J
Chromosome Res; 1995 Jun; 3(4):261-2. PubMed ID: 7606365
[TBL] [Abstract][Full Text] [Related]
15. A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP.
Zinszner H; Albalat R; Ron D
Genes Dev; 1994 Nov; 8(21):2513-26. PubMed ID: 7958914
[TBL] [Abstract][Full Text] [Related]
16. Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11).
Aman P; Ron D; Mandahl N; Fioretos T; Heim S; Arheden K; Willén H; Rydholm A; Mitelman F
Genes Chromosomes Cancer; 1992 Nov; 5(4):278-85. PubMed ID: 1283316
[TBL] [Abstract][Full Text] [Related]
17. Amplification of the MDM2 gene, but not expression of splice variants of MDM2 MRNA, is associated with prognosis in soft tissue sarcoma.
Bartel F; Meye A; Würl P; Kappler M; Bache M; Lautenschläger C; Grünbaum U; Schmidt H; Taubert H
Int J Cancer; 2001 May; 95(3):168-75. PubMed ID: 11307150
[TBL] [Abstract][Full Text] [Related]
18. DDIT3-amplified or low-polysomic pleomorphic sarcomas without MDM2 amplification: Clinicopathological review and immunohistochemical profile of nine cases.
Mori T; Iwasaki T; Sonoda H; Kawaguchi K; Tomonaga T; Furukawa H; Sato C; Shiraishi S; Taguchi K; Tamiya S; Yoneda R; Oshiro Y; Matsunobu T; Abe C; Kuboyama Y; Ueki N; Kohashi K; Yamamoto H; Nakashima Y; Oda Y
Hum Pathol; 2024 Mar; 145():56-62. PubMed ID: 38401716
[TBL] [Abstract][Full Text] [Related]
19. p53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas.
Ikenberg H; Matthay K; Schmitt B; Bauknecht T; Kiechle-Schwarz M; Göppinger A; Pfleiderer A
Cancer; 1995 Jul; 76(1):57-66. PubMed ID: 8630877
[TBL] [Abstract][Full Text] [Related]
20. FUS/TLS-CHOP chimeric transcripts in liposarcoma tissues.
Yang X; Nagasaki K; Egawa S; Maruyama K; Futami H; Tsukada T; Yokoyama R; Beppu Y; Fukuma H; Shimoda T
Jpn J Clin Oncol; 1995 Dec; 25(6):234-9. PubMed ID: 8523819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
